TWI828265B - 血液保存容器以及血液採取器具 - Google Patents
血液保存容器以及血液採取器具 Download PDFInfo
- Publication number
- TWI828265B TWI828265B TW111129971A TW111129971A TWI828265B TW I828265 B TWI828265 B TW I828265B TW 111129971 A TW111129971 A TW 111129971A TW 111129971 A TW111129971 A TW 111129971A TW I828265 B TWI828265 B TW I828265B
- Authority
- TW
- Taiwan
- Prior art keywords
- blood
- blood collection
- storage container
- aforementioned
- flow path
- Prior art date
Links
- 239000008280 blood Substances 0.000 title claims abstract description 439
- 210000004369 blood Anatomy 0.000 title claims abstract description 436
- 238000003860 storage Methods 0.000 title claims abstract description 190
- 238000000926 separation method Methods 0.000 claims abstract description 88
- 230000002093 peripheral effect Effects 0.000 claims description 47
- 230000017531 blood circulation Effects 0.000 claims description 7
- 238000003825 pressing Methods 0.000 claims description 7
- 238000001125 extrusion Methods 0.000 claims description 6
- 238000005520 cutting process Methods 0.000 claims description 2
- 230000007423 decrease Effects 0.000 claims description 2
- 210000002381 plasma Anatomy 0.000 description 77
- 210000000601 blood cell Anatomy 0.000 description 58
- 239000000523 sample Substances 0.000 description 56
- 238000012360 testing method Methods 0.000 description 37
- 238000010790 dilution Methods 0.000 description 25
- 239000012895 dilution Substances 0.000 description 25
- 238000007689 inspection Methods 0.000 description 25
- 239000007788 liquid Substances 0.000 description 17
- 238000005259 measurement Methods 0.000 description 16
- 239000000654 additive Substances 0.000 description 15
- 238000000034 method Methods 0.000 description 15
- 239000000243 solution Substances 0.000 description 15
- 239000003085 diluting agent Substances 0.000 description 14
- 238000004458 analytical method Methods 0.000 description 13
- 238000010241 blood sampling Methods 0.000 description 13
- 238000005119 centrifugation Methods 0.000 description 13
- 239000003795 chemical substances by application Substances 0.000 description 12
- 239000004033 plastic Substances 0.000 description 12
- 229920003023 plastic Polymers 0.000 description 12
- 230000000996 additive effect Effects 0.000 description 10
- 238000009534 blood test Methods 0.000 description 10
- 239000003550 marker Substances 0.000 description 9
- 210000004180 plasmocyte Anatomy 0.000 description 8
- 238000007789 sealing Methods 0.000 description 7
- 239000000126 substance Substances 0.000 description 7
- 210000002966 serum Anatomy 0.000 description 6
- KCXVZYZYPLLWCC-UHFFFAOYSA-N EDTA Chemical compound OC(=O)CN(CC(O)=O)CCN(CC(O)=O)CC(O)=O KCXVZYZYPLLWCC-UHFFFAOYSA-N 0.000 description 5
- 238000002835 absorbance Methods 0.000 description 5
- 210000004027 cell Anatomy 0.000 description 5
- 238000005516 engineering process Methods 0.000 description 5
- 238000005534 hematocrit Methods 0.000 description 5
- 239000012528 membrane Substances 0.000 description 5
- 238000012545 processing Methods 0.000 description 5
- 239000007864 aqueous solution Substances 0.000 description 4
- 210000001808 exosome Anatomy 0.000 description 4
- 238000002156 mixing Methods 0.000 description 4
- 210000005259 peripheral blood Anatomy 0.000 description 4
- 239000011886 peripheral blood Substances 0.000 description 4
- PUZPDOWCWNUUKD-UHFFFAOYSA-M sodium fluoride Chemical compound [F-].[Na+] PUZPDOWCWNUUKD-UHFFFAOYSA-M 0.000 description 4
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 4
- 206010018910 Haemolysis Diseases 0.000 description 3
- 230000009471 action Effects 0.000 description 3
- 239000003146 anticoagulant agent Substances 0.000 description 3
- 229940127219 anticoagulant drug Drugs 0.000 description 3
- 238000011088 calibration curve Methods 0.000 description 3
- 230000008859 change Effects 0.000 description 3
- 230000006835 compression Effects 0.000 description 3
- 238000007906 compression Methods 0.000 description 3
- 201000010099 disease Diseases 0.000 description 3
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 3
- 230000005484 gravity Effects 0.000 description 3
- 230000008588 hemolysis Effects 0.000 description 3
- 238000004519 manufacturing process Methods 0.000 description 3
- 238000012123 point-of-care testing Methods 0.000 description 3
- 210000003462 vein Anatomy 0.000 description 3
- 239000006173 Good's buffer Substances 0.000 description 2
- HTTJABKRGRZYRN-UHFFFAOYSA-N Heparin Chemical compound OC1C(NC(=O)C)C(O)OC(COS(O)(=O)=O)C1OC1C(OS(O)(=O)=O)C(O)C(OC2C(C(OS(O)(=O)=O)C(OC3C(C(O)C(O)C(O3)C(O)=O)OS(O)(=O)=O)C(CO)O2)NS(O)(=O)=O)C(C(O)=O)O1 HTTJABKRGRZYRN-UHFFFAOYSA-N 0.000 description 2
- 108700011259 MicroRNAs Proteins 0.000 description 2
- 238000011481 absorbance measurement Methods 0.000 description 2
- 230000000903 blocking effect Effects 0.000 description 2
- 210000001124 body fluid Anatomy 0.000 description 2
- 239000010839 body fluid Substances 0.000 description 2
- 239000000872 buffer Substances 0.000 description 2
- 230000000694 effects Effects 0.000 description 2
- 230000007613 environmental effect Effects 0.000 description 2
- 229960002897 heparin Drugs 0.000 description 2
- 229920000669 heparin Polymers 0.000 description 2
- 230000002209 hydrophobic effect Effects 0.000 description 2
- 230000007246 mechanism Effects 0.000 description 2
- 239000002679 microRNA Substances 0.000 description 2
- 238000012986 modification Methods 0.000 description 2
- 230000004048 modification Effects 0.000 description 2
- 230000003204 osmotic effect Effects 0.000 description 2
- 230000035699 permeability Effects 0.000 description 2
- 239000008363 phosphate buffer Substances 0.000 description 2
- 239000002504 physiological saline solution Substances 0.000 description 2
- 239000005871 repellent Substances 0.000 description 2
- 239000001509 sodium citrate Substances 0.000 description 2
- NLJMYIDDQXHKNR-UHFFFAOYSA-K sodium citrate Chemical compound O.O.[Na+].[Na+].[Na+].[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O NLJMYIDDQXHKNR-UHFFFAOYSA-K 0.000 description 2
- 239000011775 sodium fluoride Substances 0.000 description 2
- 235000013024 sodium fluoride Nutrition 0.000 description 2
- -1 that is Proteins 0.000 description 2
- 239000001763 2-hydroxyethyl(trimethyl)azanium Substances 0.000 description 1
- 208000034048 Asymptomatic disease Diseases 0.000 description 1
- 235000019743 Choline chloride Nutrition 0.000 description 1
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 1
- 102000017011 Glycated Hemoglobin A Human genes 0.000 description 1
- 102000001554 Hemoglobins Human genes 0.000 description 1
- 108010054147 Hemoglobins Proteins 0.000 description 1
- 241001465754 Metazoa Species 0.000 description 1
- 241000699670 Mus sp. Species 0.000 description 1
- 206010028980 Neoplasm Diseases 0.000 description 1
- 206010057469 Vascular stenosis Diseases 0.000 description 1
- PNNCWTXUWKENPE-UHFFFAOYSA-N [N].NC(N)=O Chemical compound [N].NC(N)=O PNNCWTXUWKENPE-UHFFFAOYSA-N 0.000 description 1
- 230000001133 acceleration Effects 0.000 description 1
- 239000004676 acrylonitrile butadiene styrene Substances 0.000 description 1
- 238000001467 acupuncture Methods 0.000 description 1
- 230000008901 benefit Effects 0.000 description 1
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 description 1
- 238000012742 biochemical analysis Methods 0.000 description 1
- 230000000740 bleeding effect Effects 0.000 description 1
- 210000001772 blood platelet Anatomy 0.000 description 1
- 238000004364 calculation method Methods 0.000 description 1
- 201000011510 cancer Diseases 0.000 description 1
- 229960003178 choline chloride Drugs 0.000 description 1
- SGMZJAMFUVOLNK-UHFFFAOYSA-M choline chloride Chemical compound [Cl-].C[N+](C)(C)CCO SGMZJAMFUVOLNK-UHFFFAOYSA-M 0.000 description 1
- 150000001875 compounds Chemical class 0.000 description 1
- 230000006837 decompression Effects 0.000 description 1
- 238000013461 design Methods 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 239000012470 diluted sample Substances 0.000 description 1
- 238000007865 diluting Methods 0.000 description 1
- 210000003743 erythrocyte Anatomy 0.000 description 1
- 238000001704 evaporation Methods 0.000 description 1
- 230000008020 evaporation Effects 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 239000011521 glass Substances 0.000 description 1
- 239000008103 glucose Substances 0.000 description 1
- 108091005995 glycated hemoglobin Proteins 0.000 description 1
- 230000003862 health status Effects 0.000 description 1
- 230000002489 hematologic effect Effects 0.000 description 1
- 230000005661 hydrophobic surface Effects 0.000 description 1
- 238000002372 labelling Methods 0.000 description 1
- 210000000265 leukocyte Anatomy 0.000 description 1
- 238000011528 liquid biopsy Methods 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 238000000691 measurement method Methods 0.000 description 1
- 239000011259 mixed solution Substances 0.000 description 1
- 239000000203 mixture Substances 0.000 description 1
- 230000035772 mutation Effects 0.000 description 1
- 239000004417 polycarbonate Substances 0.000 description 1
- 229920000515 polycarbonate Polymers 0.000 description 1
- 229920000642 polymer Polymers 0.000 description 1
- 238000002360 preparation method Methods 0.000 description 1
- 102000004169 proteins and genes Human genes 0.000 description 1
- 108090000623 proteins and genes Proteins 0.000 description 1
- 238000005086 pumping Methods 0.000 description 1
- 238000000275 quality assurance Methods 0.000 description 1
- 229920002477 rna polymer Polymers 0.000 description 1
- 238000010079 rubber tapping Methods 0.000 description 1
- 238000012216 screening Methods 0.000 description 1
- 238000010206 sensitivity analysis Methods 0.000 description 1
- 238000009751 slip forming Methods 0.000 description 1
- 239000007921 spray Substances 0.000 description 1
- 238000010561 standard procedure Methods 0.000 description 1
- 239000002699 waste material Substances 0.000 description 1
Images
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61J—CONTAINERS SPECIALLY ADAPTED FOR MEDICAL OR PHARMACEUTICAL PURPOSES; DEVICES OR METHODS SPECIALLY ADAPTED FOR BRINGING PHARMACEUTICAL PRODUCTS INTO PARTICULAR PHYSICAL OR ADMINISTERING FORMS; DEVICES FOR ADMINISTERING FOOD OR MEDICINES ORALLY; BABY COMFORTERS; DEVICES FOR RECEIVING SPITTLE
- A61J1/00—Containers specially adapted for medical or pharmaceutical purposes
- A61J1/05—Containers specially adapted for medical or pharmaceutical purposes for collecting, storing or administering blood, plasma or medical fluids ; Infusion or perfusion containers
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N1/00—Sampling; Preparing specimens for investigation
- G01N1/02—Devices for withdrawing samples
- G01N1/10—Devices for withdrawing samples in the liquid or fluent state
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Pathology (AREA)
- Pharmacology & Pharmacy (AREA)
- Analytical Chemistry (AREA)
- Biochemistry (AREA)
- Physics & Mathematics (AREA)
- General Physics & Mathematics (AREA)
- Immunology (AREA)
- Hydrology & Water Resources (AREA)
- Hematology (AREA)
- Chemical & Material Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Investigating Or Analysing Biological Materials (AREA)
- Measurement Of The Respiration, Hearing Ability, Form, And Blood Characteristics Of Living Organisms (AREA)
- Medical Preparation Storing Or Oral Administration Devices (AREA)
- External Artificial Organs (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| WOPCT/JP2022/029137 | 2022-07-28 | ||
| PCT/JP2022/029137 WO2024024039A1 (ja) | 2022-07-28 | 2022-07-28 | 血液保存容器および血液採取器具 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| TWI828265B true TWI828265B (zh) | 2024-01-01 |
| TW202406525A TW202406525A (zh) | 2024-02-16 |
Family
ID=86051782
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| TW111129971A TWI828265B (zh) | 2022-07-28 | 2022-08-10 | 血液保存容器以及血液採取器具 |
Country Status (3)
| Country | Link |
|---|---|
| JP (1) | JP7261526B1 (https=) |
| TW (1) | TWI828265B (https=) |
| WO (1) | WO2024024039A1 (https=) |
Citations (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| TW214513B (https=) * | 1992-01-21 | 1993-10-11 | Gabley Male | |
| TW200942816A (en) * | 2007-11-28 | 2009-10-16 | Smart Tube Inc | Devices, systems and methods for the collection, stimulation, stabilization, and analysis of a biological sample |
| CN107921221A (zh) * | 2015-08-20 | 2018-04-17 | 泰尔茂株式会社 | 注射器用组装体、预充式注射器、外筒用密封盖及注射器用组装体包装体 |
| US20220134023A1 (en) * | 2019-07-22 | 2022-05-05 | Terumo Kabushiki Kaisha | Administrable liquid medicine preparation tool, administrable liquid medicine preparation kit, and administrable liquid medicine preparation method using the same |
| US20220160583A1 (en) * | 2019-06-13 | 2022-05-26 | Trenta2 S.r.l. | Fluid transfer system and components therefor |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2805463B2 (ja) * | 1995-10-17 | 1998-09-30 | 株式会社国宗工業所 | 液体混合器 |
| KR101110576B1 (ko) * | 2009-03-16 | 2012-02-15 | 주식회사 메디사랑 | 피알피 및 필러 추출과 피브린 생성을 위한 혈액분리 및 농축용기 |
| KR101194044B1 (ko) * | 2011-12-29 | 2012-10-24 | (주) 알메디카 | 혈액 분리 및 ｐｒｐ 농축을 위한 일체형 키트 및 이를 이용한 ｐｒｐ 추출방법 |
| WO2014104640A1 (ko) * | 2012-12-27 | 2014-07-03 | Jeon Min-Yong | 버피코트 추출키트 |
| JP2014200267A (ja) * | 2013-04-01 | 2014-10-27 | テルモ株式会社 | 採取具ケース |
| JP6658498B2 (ja) * | 2016-12-22 | 2020-03-04 | 株式会社島津製作所 | 遠心分離用試料ホルダ |
| JP6480551B1 (ja) * | 2017-12-01 | 2019-03-13 | ジャパン・メディカル・リーフ株式会社 | 血液検査用容器 |
-
2022
- 2022-07-28 JP JP2022578956A patent/JP7261526B1/ja active Active
- 2022-07-28 WO PCT/JP2022/029137 patent/WO2024024039A1/ja not_active Ceased
- 2022-08-10 TW TW111129971A patent/TWI828265B/zh active
Patent Citations (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| TW214513B (https=) * | 1992-01-21 | 1993-10-11 | Gabley Male | |
| TW200942816A (en) * | 2007-11-28 | 2009-10-16 | Smart Tube Inc | Devices, systems and methods for the collection, stimulation, stabilization, and analysis of a biological sample |
| CN107921221A (zh) * | 2015-08-20 | 2018-04-17 | 泰尔茂株式会社 | 注射器用组装体、预充式注射器、外筒用密封盖及注射器用组装体包装体 |
| US20220160583A1 (en) * | 2019-06-13 | 2022-05-26 | Trenta2 S.r.l. | Fluid transfer system and components therefor |
| US20220134023A1 (en) * | 2019-07-22 | 2022-05-05 | Terumo Kabushiki Kaisha | Administrable liquid medicine preparation tool, administrable liquid medicine preparation kit, and administrable liquid medicine preparation method using the same |
Also Published As
| Publication number | Publication date |
|---|---|
| JP7261526B1 (ja) | 2023-04-20 |
| WO2024024039A1 (ja) | 2024-02-01 |
| JPWO2024024039A1 (https=) | 2024-02-01 |
| TW202406525A (zh) | 2024-02-16 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP6431555B2 (ja) | 生体液分離装置 | |
| JP6177996B2 (ja) | 生体液収集装置および生体液分離試験システム | |
| US9808192B2 (en) | Biological fluid sampling transfer device and biological fluid separation and testing system | |
| KR101136654B1 (ko) | 시료채취 및 분석 기구 | |
| CN1902484B (zh) | 一次性流体试样采集装置 | |
| CN107532973B (zh) | 试样提取分离器 | |
| JP2016518924A (ja) | 生体液採集装置、および、生体液採集検査システム | |
| JP2009122082A (ja) | 血液希釈定量器具 | |
| WO2019107509A1 (ja) | 血液検査用容器 | |
| JP2023062899A (ja) | 血液保存容器および血液採取器具 | |
| TWI828265B (zh) | 血液保存容器以及血液採取器具 | |
| JP2007167123A (ja) | 真空採血管 | |
| JP2007167124A (ja) | 真空採血管 |